Table 3.
N = 439 | BAV (n = 140) |
TAV (n = 299) |
Crude OR (95% CI) |
Adjusted ORa (95% CI) |
---|---|---|---|---|
I. Aortic valve procedures | ||||
Isolated valve prosthesisb, n (%) | 104 (74) | 275 (92) | 0.25 (0.14–0.44) | 0.49 (0.26–0.92) |
– Bentall procedure, n (%) | 28 (20)* | 19 (6.4) | 3.68 (1.98–6.87) | ‡ |
– Aortic root replacementc, n (%) | 2 (1.4) | 2 (0.7) | 2.15 (0.30–15.4) | – |
– Other aortic valve proceduresd, n (%) | 6 (4.3) | 3 (1.0) | 4.42 (1.09–17.9) | ‡ |
II. Additional procedures | ||||
CABG, n (%) | 20 (14) | 118 (39) | 0.26 (0.15–0.43) | 0.45 (0.25–0.83) |
SCAR, n (%) | 8 (5.7) | 5 (1.7) | 3.56 (1.14–11.1) | ‡ |
Arch replacement, n (%) | 11 (7.9) | 8 (2.7) | 3.10 (1.21–7.89) | ‡ |
Other aortic surgerye, n (%) | 7 (5.0)* | 8 (2.7) | 1.63 (0.55–4.79) | – |
Mitral and/or tricuspid surgery, n (%) | 11 (7.9) | 41 (14) | 0.54 (0.27–1.79) | – |
Other cardiac surgeryf, n (%) | 8 (5.7) | 29 (9.7) | 0.56 (0.25–1.27) | – |
III. ‘Proximal aortic surgery’ | 44 (31) | 34 (11) | 3.57 (2.16–5.92) | 2.3 (1.3–4.0) |
BAV bicuspid aortic valve, CABG coronary artery bypass grafting, CI confidence interval, OR odds ratio, SCAR supracoronary ascending replacement, TAV tricuspid aortic valve
*P < 0.001; ‡ numbers too small for multivariable analysis
aAdjusted for age at surgery, gender, years since surgery, hypertension, hypercholesterolemia and diabetes
bMechanical or biological
cTwo cases of endocarditis and two cases of elective homograft by choice
dHomograft (n = 2), autograft (n = 4), valvuloplasty (n = 3)
eAscending aorta reefing/patch enlargement
fCongenital correction (n = 8), rhythm surgery (n = 16), Morrow procedure (n = 3), myxoma, and various patch-plasties